Interference of the IGF system as a strategy to inhibit breast cancer growth.
about
Association of insulin receptor substrate 1 with simian virus 40 large T antigenEnhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acidEffects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cellsProtein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation.The contradictions of the insulin-like growth factor 1 receptor.Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulationSelective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells.Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.Targeting the insulin-like growth factor axis as a cancer therapy.GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.Insulin-like growth factor I receptor signaling in transformation by src oncogenes.A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor.The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells.In vitro and in vivo studies of the combination of IGF1R inhibitor figitumumab (CP-751,871) with HER2 inhibitors trastuzumab and neratinib.IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.Breast cancer cell survival signal is affected by bergapten combined with an ultraviolet irradiation.Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells.Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor.Type I insulin-like growth factor receptor function in breast cancer.Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor.Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.
P2860
Q24307564-64471D17-34E1-47DB-A1E8-18F54BC57E17Q24562115-48F55CFD-6D72-4B20-BA40-F29EA96326D4Q33605964-102027FF-9E57-48A3-A5E8-2180A7D478CCQ33780757-A9BB8C3C-1208-494E-B22D-D44B1AFFAB22Q34103628-87AE0493-CF47-4861-BBCC-94691A155AA6Q34387886-BF813278-143C-4428-AFF4-D67A16A34E3BQ34580753-81319CEF-4E8D-4522-8F18-647EC0E8130DQ34928974-22F838F6-36A2-4604-8D1B-7126098B2BEAQ36138971-4D953C82-4512-45D0-8944-81DCBB349F56Q36429684-EF6027BE-7898-490C-B363-A259C8E2249DQ36547331-56225E33-25AC-4344-98A5-A68BE1E3A759Q36569121-45998A81-F8B6-4D54-90F6-046DC1725394Q36656841-72B5DB50-7E4D-4973-B1ED-90C607E0A03EQ38327469-9783006A-7149-425D-8E16-2814DE3BA89AQ38850952-DFC285BC-AE50-4BD5-B57E-C33C7E13E8E9Q39016042-B2440FF6-2BFD-4DC0-996D-4BCC4B90F2AEQ39718350-CB76BE84-4476-48DE-A33D-B08CA6C5B2C4Q40219858-210AE4FE-8971-4088-BD9C-E75A2A2ABE50Q40699814-50B58B28-E7E5-4488-A5B9-B4F57D7BD61DQ41197904-B2A5BDD5-D85C-4E9A-80DC-F42F2B0F4F3FQ41727242-31964B01-93FF-42A4-B3A6-43EB3A4FDD6DQ42824230-0170C07F-F5D6-4077-BFAD-122F7A242867Q53197894-46B8AB52-C822-45CD-9F7D-D5FE6D1AEC02
P2860
Interference of the IGF system as a strategy to inhibit breast cancer growth.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Interference of the IGF system as a strategy to inhibit breast cancer growth.
@ast
Interference of the IGF system as a strategy to inhibit breast cancer growth.
@en
type
label
Interference of the IGF system as a strategy to inhibit breast cancer growth.
@ast
Interference of the IGF system as a strategy to inhibit breast cancer growth.
@en
prefLabel
Interference of the IGF system as a strategy to inhibit breast cancer growth.
@ast
Interference of the IGF system as a strategy to inhibit breast cancer growth.
@en
P356
P1476
Interference of the IGF system as a strategy to inhibit breast cancer growth.
@en
P2093
Arteaga CL
P2888
P304
P356
10.1007/BF01833338
P407
P577
1992-01-01T00:00:00Z